Date: Thursday, March 28, 2019
Time: 11am ET / 8am PT
It was reported that over 79,000 people died of flu in the U.S. in the winter of 2017-2018, which was the highest death toll in four decades.1 It seems like the 2018-2019 flu season isn’t so bad. How are sales of OTC drugs impacted by the severity of flu seasons? Are there any opportunities for new products to capture market share? How can companies ensure reliable supply of OTC medications based upon expected spikes in demand?
Register for the webinar to learn the answers to these critical questions from industry experts. We will review the current OTC remedies for cough, cold and allergy categories and discuss strategies to grow your share on shelf space with innovative dosage forms.
IRI Product Management
Director of Product Development, Asia Pacific
Catalent Pharma Solutions